Follow-The-Filings

Security · featured owners

RNA Atrium Therapeutics Inc.

Health Care COM Equity as of 2026 Q2 among managers we track

  • 1 Owner
  • Max 0.3%
  • $2M
  • 1 new 1 exit

RNA (Atrium Therapeutics Inc.) is held in 1 featured 13F book as of 2026 Q2. Nathan Fischel - Dafna Capital Management is the largest tracked holder by portfolio weight (0.33%). Figures are as-filed 13F, not free float.

Who owns this now

Largest portfolio weights among featured holders · max 0.3% (Nathan Fischel - Dafna Capital Management) · not free-float ownership

  1. Nathan Fischel new 0.33%

holders

sorted by value · long equity only · current book 2026 Q2 · open a manager for their book

history
Nathan Fischel - Dafna Capital Management 2026 Q2 0.33% New 0.33% 128,000 $2M history
Farallon Capital Management exited 2026 Q2 last 2026 Q1 0.03% Exit −0.03% 349,360 $5M history

1 current · 1 exited last period · options excluded

SEC filings

Recent issuer filings from EDGAR · 7 shown · open Filing / Doc on SEC.gov

Filed Form Detail Links
8-K 2.02,9.01 Filing Doc
10-Q Filing Doc
8-K 8.01,9.01 Filing Doc
8-K 2.02,9.01 Filing Doc
10-Q Filing Doc
8-K 1.01,5.01,5.02,9.01 Filing Doc
8-K 7.01,9.01 Filing Doc

Insider forms

Form 3 / 4 / 5 from EDGAR · 3 rows shown

Filed Form Detail Links
4 Period Apr 20, 2026 · 6 forms Filing Doc
4 Period Feb 27, 2026 · 5 forms Filing Doc
3 Period Feb 26, 2026 · 11 forms Filing Doc

Updated 26 days ago Source: SEC EDGAR submissions All on EDGAR

financials

US-GAAP annual · as tagged in Form 10-K

newly public · no 10-K financials yet · 10-Q

ownership over time

filing count by report period · click a bar for that quarter’s holders